Observational studyVascular health and risk management2018

All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study.

Luca Degli Esposti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.